Status: Not yet recruiting
ALPs Single ChambEr New Device Study
Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.
Participants needed: 15
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Cairdac SAUpdated: Mar 18, 2026
Eligibility criteria
Male or female, ≥ 18 years of age at enrolment [+7]
Subject who is entirely pacemaker dependent (escape rhythm <30 bpm). [+17]